EU Orphan Law A 'Remarkable Success' But Approval Speed and Patient Access Still Poor

While the 15-year old EU orphan drugs legislation has "significantly helped to accelerate the translation of science into therapies for patients with rare diseases", orphan drugs are still not being approved - or reaching the patients who need them- fast enough.